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The equine alveolar macrophage: Functional and 
phenotypic comparisons with peritoneal macrophages 
Anna E. Karagianni, Ronan Kapetanovic, Bruce C. McGorum, David A. Hume and Scott R. 
Pirie. 
 
Abstract 
Alveolar macrophages (AMs) constitute the first line of defence in the lung of all species, 
playing a crucial role in the regulation of immune responses to inhaled pathogens. A 
detailed understanding of the function and phenotype of AMs is a necessary pre-
requisite to both elucidating their role in preventing opportunistic bacterial 
colonisation of the lower respiratory tract and developing appropriate preventative 
strategies. The purpose of the study was to characterise this important innate immune 
cell at the tissue level by making functional and phenotypic comparisons with 
peritoneal macrophages (PMs). We hypothesised that the tissue of origin determines a 
unique phenotype of AMs, which may constitute an appropriate therapeutic target for 
certain equine respiratory diseases. Macrophages isolated from the lung and the 
peritoneal cavity of 9 horses were stimulated with various toll like receptor (TLR) 
ligands and the production of nitrite, tumour necrosis factor alpha (TNFα), interleukin 
(IL) 10 and indoleamine 2,3-dioxygenase (IDO) were measured by the Griess reaction 
and enzyme linked immunosorbent assay (ELISA) and/or quantitative polymerase 
chain reaction, respectively. Cells were also compared on the basis of phagocytic-
capacity and the expression of several cell surface markers. AMs, but not PMs, 
demonstrated increased TNFα release following stimulation with LPS, polyinosinic 
polycytidylic acid (Poly IC) and heat-killed Salmonella typhinurium and increased TNFα 
and IDO mRNA expression when stimulated with LPS. AMs showed high expression of 
the specific macrophage markers cluster of differentiation (CD) 14, CD163 and TLR4, 
whereas PMs showed high expression of TLR4 only. AMs, but not PMs, demonstrated 
efficient phagocytic activity. Our results demonstrate that AMs are more active than 
PMs when stimulated with various pro-inflammatory ligands, thus supporting the 
importance of the local microenvironment in the activation status of the macrophage. 
This information provides a valuable knowledge base on which to improve our 
understanding of the role of macrophages and their microenvironment in equine innate 
immunity. 
 
Abbreviations 
AMs, alveolar macrophages; BALF, bronchoalveolar lavage fluid; CD, cluster of 
differentiation; cDNA, complementary DNA; FS, forward scatter; HS, horse serum; IAD, 
inflammatory airway disease; MD2, myeloid differentiation factor 2; NO, nitric oxide; 
PL, peritoneal lavage; PMs, peritoneal macrophages; Poly IC, polyinosinic polycytidylic 
acid; qPCR, quantitative PCR; RIN, RNA integrity number; RPMI, Roswell Park 
Memorial Institute; SC, side scatter; TLR, toll-like receptor 
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1.Introduction 
Opportunistic respiratory infections, often with upper airway commensal bacteria, are a 
recognised cause of lower respiratory tract disease in the horse. Such infections can 
result in a variety of diseases of varying severity, ranging from subtle athletic 
performance limitation to life-threatening fulminant pleuropneumonia (Wlaschitz and 
Scherzer, 2000; Robinson and Hoffman, 2003; Wood et al., 2005; Ferrucci et al., 2008). 
Although specific risk factors associated with such infections have been well documented 
(Robinson and Hoffman, 2003; Cardwell, 2009), there remains a lack of understanding 
of the precise mechanisms which permit colonisation of the lower respiratory tract by 
otherwise non-pathogenic bacteria, although this is likely to be partly attributable to 
either suppression of the innate immune response and/or an “overwhelming” of its 
capabilities. 
As a component of the mononuclear phagocyte system (MPS), alveolar macrophages 
play a pivotal role in the innate immune response of the lung. The MPS comprises 
resident innate immune cells found in large numbers in every tissue of the body, 
especially at portals of pathogen entry such as the lungs or the intestines. From their 
progenitor in the bone-marrow, cells differentiate into monocytes under the influence of 
hematopoietic factors such as the macrophage CSF (M-CSF or CSF-1), following which 
they are recruited to various different tissues (Hume et al., 2002; Hume, 2008), which 
they populate as resident macrophages. At these resident sites, they recognise non self-
components of potential pathogens, so-called pathogen-associated molecular patterns 
(PAMPs), a process mediated through families of pattern recognition receptors on the 
cell surface, within the endocytic pathways and in the cytoplasm (Kumar et al., 2011), 
resulting in the production of inflammatory molecules and antimicrobial effectors 
(Hume et al., 2002). Despite their identical lineage, work in other species has identified 
a unique phenotype of the alveolar macrophage, compared with macrophages derived 
from other anatomical sites, a finding thought to reflect the distinctive 
microenvironment of this cell and its “breath-by-breath” exposure to ambient air 
containing a variety of potential allergenic and pro-inflammatory components (Guth et 
al., 2009). In order to further elucidate the potential role of macrophage suppression in 
various opportunistic bacterial airway diseases in the horse, we considered it essential to 
further characterise its basic function and phenotype by making specific comparisons 
with other tissue derived macrophages. The peritoneal cavity constitutes an abundant 
source of macrophages for such comparative purposes. Furthermore, although 
peritoneal macrophages have been studied in great detail in mice (Zhang and Morrison, 
1993; Katakami et al., 1988; Sherry et al., 2007) and to a lesser extent in humans 
(Hetland and Bungum, 1988; Halme, 1989), there have been relatively few studies of the 
functions of peritoneal macrophage populations of the horse (Morris et al., 1992; 
Hawkins et al., 1998; Laan et al., 2005, 2006). Therefore novel phenotypic and 
functional data was obtained from macrophages harvested from the peritoneal cavity 
and airways of horses and appropriate comparisons made. 
 
1.Materials and methods 
2.1 Animals 
Nine horses (median age: 16 yrs, range: 4–22) were admitted to the Equine Hospital at 
the Royal (Dick) School of Veterinary Studies for elective euthanasia. Horses were 
euthanased by the i.v. administration of cinchocaine hydrochloride (25 mg/ml) and 
secobarbital sodium (400 mg/ml) (Somulose™, Arnolds/Dechra, UK), via a pre-placed 
14 gauge i.v. jugular catheter. All of the animals were systemically healthy, none had a 
chronic or immediate history of respiratory disease and post-mortemexamination 
confirmed the absence of gross lung pathology in all 9 horses. The Veterinary Ethical 
Review Committee of the School of Veterinary Medicine, University of Edinburgh 
approved all the protocols involving the use of post-mortemmaterial from these animals. 
 
2.2. Isolation of alveolar (AMs) and peritoneal macrophages (PMs) 
Following euthanasia, the trachea was exposed, transected and occluded proximally to 
prevent blood contamination of the lungs. The thorax was opened and the lungs, with 
trachea attached, were removed and transferred to a clean working area. The trachea was 
further transected at a level approximately 15 cm from the carina. Two litres of sterile 
PBS (D1408, Sigma–Aldrich, USA) were instilled into the lungs, either directly into the 
trachea or via a cuffed endotracheal tube. Following gentle massage of the lungs, the 
bronchoalveolar lavage fluid (BALF) was retrieved by gravity following elevation of the 
lungs above the level of the distal trachea. 
For peritoneal lavage, an incision was made in an aseptically prepared area of the ventral 
abdominal midline down to the level of the linea alba, through which a catheter and 
trocar were inserted into the peritoneal cavity. Following removal of the trocar, 6 litres of 
sterile PBS was infused into the peritoneal cavity by gravity. Following abdominal 
ballottement, the horse was hoisted by the pelvic limbs and the peritoneal cavity opened 
carefully. The instilled fluid, which had gravitated to a level immediately caudal to the 
liver, was visualised and retrieved by siphoning through a 1 m length of sterile tubing. 
For both the lung and peritoneal lavage, the retrieved fluid was immediately placed on 
ice and processed within 30 min of collection. Cells were processed as previously 
described (Laan et al., 2005). Briefly, the fluid was filtered (100 μm cell strainer) and 
decanted into 500 ml falcon tubes and centrifuged at 400 × g for 10 min at 10 °C. 
Supernatant was removed carefully and the cell pellets re-suspended in PBS and 
transferred to a 50 ml falcon tube which was further centrifuged at 400 × g for 5 min at 
10 °C. The cell pellet was re-suspended in 1 ml of RPMI-1640 (Sigma–Aldrich, UK) and 
manually counted using a haemocytometer. Viability was assessed by adding Trypan 
blue 0.4%. When grossly visible blood contamination was evident, red cells lysis buffer 
was added for 5 min (10 mM KHCO3, 150 mM NH4Cl, 0.1 mM EDTA pH 8.0) followed by 
the addition of PBS. 
An aliquot was retained for cytological analysis as described previously (Miyamoto et al., 
2003). Briefly, cell numbers were adjusted to 4–5 × 105 cells/ml by the addition of a 
calculated volume of PBS. From this aliquot, 2 cytospin slide preparations were made 
per lavage (cytospined at 300 rpm for 3 min) and stained (Leishman stain; 
L/1815L/PB05, Fisher Scientific, Leicestershire, UK) and a differential cell count 
calculated under light microscopy by counting 500 cells (Hoffman, 1999). Cells were 
cryopreserved in FCS 90%, DMSO 10% (Sigma–Aldrich, USA) and kept frozen for later 
use. 
2.3 Cell culture 
Cells were seeded in 6 well plastic plates (Nunc, Thermo Scientific, Wilmington, 
USA) at 1 × 106 cells/ml in complete medium: RPMI-1640 medium supplemented 
with GlutaMAX™-I Supplement (Invitrogen Ltd., Paisley, UK), 
penicillin/streptomycin (Invitrogen Ltd., Paisley, UK) and 10% heat-inactivated 
Horse Serum (HS – Sigma Aldrich, cat no: H1138). Plates were incubated at 37 °C 
and 5% CO2 overnight. The following day, non-adherent cells were removed. New 
complete medium was added and adherent cells were stimulated with different 
agonists: LPS (10 ng/ml and 100 ng/ml) from Salmonella enterica serotype 
Minnesota Re 595 (L9764, Sigma–Aldrich, USA), heat killed Salmonella typhinurium 
(106 cfu/ml, 107 cfu/ml and 108 cfu/ml) and Poly IC-LMW (Invitrogen, San Diego, 
USA) (2 μg/ml). Supernatant from the plates was collected at various time-points (0, 
2, 6 and 24 h) following stimulation. 
 
2.4. TNFα, IL10 and nitric NO assay 
Equine TNFα and IL10 protein production in cell culture supernatants was 
measured using the DuoSet ELISA kit (R&D systems, Minneapolis, MN) according to 
the manufacturer's instructions. NO is unstable and it is rapidly converted to nitrite. 
Thus, nitrite was measured as the end product of NO by Griess reaction as 
previously described (Gross and Levi, 1992). Positive and negative controls were 
obtained by using RAW-274.1 cells treated with LPS (10 and 100 ng/ml) for 6 h. OD 
was read on a Multiskan v2.6 (Thermo Scientific, Wilmington, USA) at 540 nm and 
data was analysed using Ascent software. Inclusion criteria for the macrophage 
characterisation were their ability to adhere to the plastic plates for the cytokine 
and (nitric oxide) NO analysis (Grünig et al., 1991; Hawkins et al., 1998; Moore et al., 
2003). 
2.5. RNA extraction and quantitative PCR (qPCR) 
Following the removal of the cell supernatant at 0 and 6 h post stimulation, total 
RNA was extracted using RNA-Bee (Amsbio, Abingdon, UK) according to the 
manufacturer's instructions from both AMs and PMs of 6 and 4 different horses, 
respectively. RNA concentration and purity was measured using ND-1000 Nanodrop 
(Thermo Scientific, Wilmington, USA). RNA integrity was also confirmed with RNA 
6000 Pico Assay (Agilent Technologies). RNA integrity number (RIN) greater than 7 
was considered appropriate for qPCR use. One microgram total RNA was converted 
to complementary DNA (cDNA) using the prescription NanoScript reverse 
transcription kit (RT – NanoScript, Primer Design), according to the manufacturer's 
instruction. cDNA was stored at −20 °C until further use. 
In order to select our reference gene, cDNA of the samples (4 LPS treated and 4 
untreated) was diluted in RNA/DNA free water to a concentration of 5 ng/ml and 5 
μl of each was added to Light Cycler 480 SYBR Green I master mix (Roche). The 
establishment of the optimal reference genes was performed by using the geNorm™ 
reference gene selection kit (Primerdesign), according to manufactures instructions. 
Primers for TNFα and indoleamine 2,3-dioxygenase (IDO) were also provided by 
Primerdesign. Sense and anti-sense primer sequence for TNFα were 
ATCTACTCCCAGGTCCTCTTC and CGTGTTGGCAAGGCTCTT, respectively and for IDO 
ATCAAAGAAATTCCGTTATATTCAA and TGCGTAGACAAGAAGAAGTTATATCAAT, 
respectively. Quantitative PCR was performed in triplicate according to the custom 
designed real-time PCR assay from Primerdesign. 18S was used as a housekeeping 
gene according to the results of the GeNorm kit used in the current study (sense 
primer sequence: CGGACAGGATTGACAGATTGATA, anti-sense primer: 
TGCCAGAGTCTCGTTCGTTA). 
 
2.6. Flow cytometry 
Cells were added to plate wells, as previously described, left overnight and the 
following morning the medium and non-adherent cells were removed. Remaining 
adherent cells were gently detached by the use of cell scarpers and 500 μl PBS. One 
million cells per flow cytometry tube were used for the assay. After 30 min 
incubation with high-block solution (PBS, 0.1% NaN3, 2% FCS, 0.1%BSA), cells were 
washed twice with low-block solution (PBS, 0.1% NaN3, 0.2% FCS, 0.1%BSA). Cells 
were then stained with mouse monoclonal anti-equine CD14 IgG1 Ab (Clone 105, 2 
mg/ml, Bettina Wagner Research Lab), goat polyclonal anti-human TLR4 antibody 
(M-16:sc-12511) and a mouse anti-human macrophage surface Ag monoclonal (AM-
3K; Gentaur, product number: KT013) targeting CD163. A goat (Fab2) anti-mouse 
secondary IgG Ab (RPE Serotec) was used for the CD14 and CD163 Ab staining, 
while a donkey secondary anti-goat (Alexa-Fluor 633, Life A21082) was used for the 
TLR4 staining. A negative/isotype control was used for each sample and was stained 
with only the secondary antibody to control for non-specific binding. Cells were then 
washed, resuspended in 500 μl of PBS and analysed using CyAn™ ADP Analyser 
(Beckman Coulter, High Wycombe, UK) and Summit v4.3 software. Data were 
acquired on 10,000 events and cells gated (Fig. 3A and B) according to size (FS: 
forward scatter) and granularity (SS: side scatter). Sytox blue dead cell stain 
(Invitrogen, Catalogue No. S34857) was used in order to measure the viability of 
cells (97%). Inclusion criteria for the macrophage characterisation were apart from 
their ability to adhere to the plastic plates, their large size and granularity (forward 
and side scatter, respectively) observed by flow cytometry (Grünig et al., 1991; 
Hawkins et al., 1998; Moore et al., 2003; Werners et al., 2004). 
 Fig.3 
CD14, CD163 and TLR expression on equine macrophages. Alveolar and 
peritoneal cells were seeded at 106 cells/ml and left to rest overnight. The next 
day non-adherent cells were washed away and cells were stained for flow 
cytometry. Size (FS) and granularity (SS) were used for the cell differentiation 
and their gating (A and B). Alveolar and peritoneal macrophages were stained for 
CD14, TLR4 and CD163. Isotype controls are represented by a non-hatched curve 
and targeting antibody is represented by a hatched curve. Figures are 
representative of one out of a minimum of 4 experiments. Median fluorescence 
intensity of the CD14 Ab was 25.88 ± 3.8 for the AMs and 4.96 ± 1.5 for the PMs 
(C and F). Median fluorescence intensity of the TLR4 was 5.89 ± 1.7 for the AMs 
and 5.1 ± 2.1 for the PMs (D and G). 11.63 ± 2.6 was the median fluorescence 
intensity of the AMs and 7.68 for the PMs (E and H). The median fluorescence 
intensity represents the mean of a minimum of 4 experiments ± SEM. 
 
2.7. Phagocytosis assay 
Cells were seeded in duplicate (1 × 106 cells/ml), in Petri dishes (w/2 mm Grid 
430196, 60 mm × 15 mm style, Corning Incorporated NY 14831) in complete 
medium (supplemented only with HS) and left overnight at 37 °C, 5% CO2. The 
following morning two plates were incubated at 4 °C for at least 30 min. Medium 
from all plates were refreshed with warm and cold cell culture media as above, 
respectively, thus, non-adherent cells were removed. Heat-killed Escherichia coli 
bioparticles (E2861, K-12 strain, 10 mg) were added at a ratio of 10 bacteria for 
1 cell in one plate at 37 °C and one at 4 °C. No bacteria were added to the 
remaining 4 °C and 37 °C plates; these were incorporated to control for 
autofluorescence. Paired plates were incubated for 1 h at 4 °C and 37 °C, 
respectively, to allow particle uptake. We measured the number of FITC-labelled 
Escherichia coli bioparticles in AMs and PMs, which could phagocytose at 37 °C. 
The 4 °C condition was incorporated to reveal the presence of surface adherent 
bacteria only, as phagocytosis is inhibited at this temperature. All cells were 
washed twice with cold PBS and were gently collected with cell scrapers. Cells 
were then centrifuged at 400 × g for 5 min, resuspended in 500 ml of cold PBS 
and analysed on a CyAn™ ADP Analyser, as above. 
 
 
 
 
            2.8. Statistical analysis 
Descriptive statistics were performed using Mini Tab 16 statistical software. 
After testing for normality, a one-sample Wilcoxon test was employed to identify 
differences in TNFα production between untreated cells (controls) and cells 
incubated for 2 h and 6 h after LPs stimulation. Statistical significance was 
assumed at p < 0.05. Numeric results are presented as mean ± SEM. 
 
       3.  Results 
3.1. Cell recovery and populations 
Approximately 2.35 × 108 (±51.6) AMs and 1.33 × 108 (±17.3) PMs were 
reproducibly isolated from each of 9 systemically healthy horses. Cell viability on 
the day of cell harvesting was greater than 90% as assessed by Trypan blue (data 
not shown). Differential cell counts of raw BALF and peritoneal lavage (PL) fluid, 
as assessed by light microscopy, are summarised in Table 1. Following overnight 
culture and removal of non-adherent cells, more than 95% of adherent cells were 
identified morphologically as macrophages after performing a Leishman stain on 
the culture plates, for both AMs and PMs. 
  
Table 1 
Differential cell count of alveolar and peritoneal lavage. 
 
3.2. Response of AMs and PMs to inflammatory stimulus 
To investigate the relative responsiveness of AMs and PMs to LPS, cells were plated 
at a concentration of 106 cells/ml and left to rest overnight in HS, as mentioned 
above. The next day, medium was refreshed; cells were stimulated with LPS. The 
supernatant concentration of TNFα was measured prior to and 2 h and 6 h following 
stimulation with LPS. No statistically significant difference was observed between 
low and high dose of LPS treatment (Fig. 1A and B). LPS-induced TNFα production 
by AMs was detected by 2 h and was statistically significant higher compared to 
untreated cells. PMs did not show any LPS-induced TNFα production. Culture 
supernatant TNFα concentration measured at 24 h post LPS stimulation of AMs was 
not significantly different from that measured at the 6 h time point, suggesting that a 
peak in TNFα concentration is reached between 6 h and 24 h (data not shown). At 
24 h, there was still no detectable TNFα production by PMs (data not shown). To 
determine whether the lack of responsiveness of PMs could be attributed to a 
deficiency in the TLR4 pathway, we stimulated both AMs and PMs with other 
agonists containing alternative ligands. These included Poly IC (2 μg/ml, a TLR3 
ligand) and heat-killed bacteria Salmonella typhimurium (106 cfu/ml, 107 cfu/ml and 
108 cfu/ml) that contain a mixture of TLR4 (LPS), TLR2 (peptidoglycan), TLR9 (CpG) 
and TLR5 ligands (flagelin) (Fig. 1C and D respectively). AMs, but not PMs produced 
TNFα in response to these stimuli. IL-10 levels remained almost undetectable in 
both AM and PM at all-time points (data not shown). 
 
Fig.1 
TNF production of AMs and PMs in response to inflammatory stimuli. Alveolar and 
peritoneal cells were seeded at 106 cells/ml and left to rest overnight. The next day non-
adherent cells were washed away and cell media was refreshed with HS. AMs and PMs 
were stimulated with 10 and 100 ng/ml of LPS for 0 h, 2 h and 6 h (A and B). AMs and 
PMs were alsostimulated with 2000 ng/ml of PolyIC for 6 h (B) and with 3 doses of 
Salmonella thyphimurium (106, 107 and 108 cfu/ml) (C). Results are the mean of a 
minimum of 4 experiments ± SEM (*p < 0.05 versus control 0 h). 
 
3.3. LPS-induced TNFα and IDO mRNA expression in AMs and PMs 
RNA was extracted from AMs and PMs at 0 h and 6 h following LPS (100 ng/ml) 
stimulation, providing an average yield of 175.82 ng/μl of RNA (±37.9) for AMs and 
51.02 ng/μl (±10.1) for PMs. Reference gene selection was based on widely published 
housekeeping genes used in several horse studies. GAPDH and ACTB were repeatedly 
used in many experiments performed on BALF derived cells (Laan et al., 2006; Perkins 
et al., 2008; Riihimaki et al., 2008; Reyner et al., 2009; Beekman et al., 2011; Hughes et 
al., 2011) and other genes such as HPRT1, SDHA, 18S, B2M, 28S have been investigated 
in other equine tissue cells (Cappelli et al., 2008; Zhang et al., 2009). In order to select 
the most appropriate reference gene for the equine macrophage-based studies, we 
ranked 6 candidate reference genes based on their M value, as assessed using GeNorm 
(qBaseplus software) (data not shown). An M-value describes the variation of a gene 
compared to all other candidate genes and the gene with the lowest M-value was 
considered to be the most stable gene (Vandesompele et al., 2002). We found 18S to be 
the most stable gene compared to B2M, ACTB, HPRT1 and SDHA (Fig. 2A). Interestingly, 
we found the commonly used GAPDH to be the least stable gene of the group. In 
agreement with the results of the TNFα ELISA results, only AMs showed an up-
regulation of TNF transcript, which was statistically significant between LPS treated 
AMs and controls (Fig. 2B). Similarly, IDO expression was also statistically significantly 
up-regulated in the horse treated AMs but was not expressed in PMs (Fig. 2C). 
 
Fig.2 
mRNA expression of TNF and IDO production of AMs and PMs in response to 
LPS. (A) GeNorm (qBaseplus software) was used for the ranking of the six 
candidate reference genes based on their M value. All reference genes had values 
less than 1.5 which is the cutoff point under which genes are considered to be 
stably expressed. 18S was identified as the most stable gene. Quantitative PCR of 
the TNF (B) and IDO (C) transcripts, respectively, were performed on cDNA 
samples of both AMs and PMs and mRNA expression was normalised to 18S. 
Results are the mean of a minimum of 4 experiments ± SEM (*p < 0.05 versus 
control 0 h). 
 
3.4. CD14, CD163 and TLR4 expression on AMs and PMs 
In a further attempt to investigate the lack of LPS-responsiveness of PMs, we 
evaluated the relative expression of various relevant cell surface markers. These 
included the LPS receptor TLR4 and its co-receptor CD14. Expression of CD163, a 
scavenger R and common macrophage marker was also evaluated. Cells were 
gated, as shown in Fig. 3A and B. AMs highly express CD14, TLR4 and CD163 (Fig. 
3C–E). In contrast, PMs although showing an equivalent expression of TLR4 to 
AMs, expressed very low levels of CD14 and CD163 (Fig. 3F–C). 
 
3.5 Phagocytic properties of AMs and PMs 
As the morphological assessment of PMs revealed them to be significantly 
smaller and less ruffled, compared with AMs (data not shown), we further 
investigated whether this difference in appearance reflected a difference in 
phagocytic capability. Compared to AMs, PMs phagocytosed a significantly lower 
number of FITC-labelled E. coli, thus indicating a relative deficiency in their 
ability internalise despite an apparent ability to bind, bacteria. The average of 
median fluorescence of the populations (AMs and PMs) at 4 °C and 37 °C is 
presented in Fig. 4. 
 Fig.4 
AMs, but not PMs, can phagocyte bacteria. Alveolar and peritoneal cells were 
seeded at 106 cells/ml into 2 different plates and left to rest overnight. The next 
day non-adherent cells were washed away and cell media was refreshed with HS. 
One plate was left at 4 °C in order to inhibit phagocytosis while the other was left 
at 37 °C for 30 min. FITC-labelled Escherichia coli at a concentration of 16.5 
μg/ml (MOI of 10:1) were added into the wells for 1 h. Cells were then washed 
twice and analysed by flow cytometry. Control cells at 37 °C and 4 °C, were 
included in the experiment as well as cells with E. coli are at 37 °C and 4 °C. Mean 
of the median fluorescence intensity of the 3 experiments ± SEM is shown in the 
figure AMs are in black bars and PMs in grey bars. 
3.6. LPS-induced NO production by AMs and PMs 
Nitric oxide has been attributed many functions in host defence based largely 
upon studies in rodents (Ito et al., 2005; Takacs et al., 2012). Hammond et al. 
reported that equine lung macrophages can induce iNOS, and produce nitric 
oxide, in response to LPS (Hammond et al., 1999). In order to investigate 
whether equine-derived macrophages produce NO, we stimulated both AMs and 
PMs with LPS (100 ng/ml) for 0 h and 6 h and measured the subsequent 
production of nitrite. As a positive control cell population, we used the mouse 
macrophage cell line RAW 274.1, known to produce NO in response to LPS. In 
comparison to the mouse cell line, which produced abundant nitrite, no nitrite 
was detected in the supernatant of LPS-stimulated equine AMs or PMs (Fig. 5). 
 
Fig.5 
Production of Nitrite by horse macrophages. Alveolar and peritoneal cells were 
seeded at 106 cells/ml and left to rest overnight. The next day non-adherent cells 
were washed away and cell were stimulated by 100 ng/ml of LPS for 0 h and 6 h 
in presence of HS. Mouse macrophage RAW 274.1 was used as control. 
 
4.Discussion 
This study, as well as providing functional and phenotypic data on equine AMs 
and PMs, has demonstrated significant differences between these cell 
populations. AMs showed all the characteristics of potent macrophages like 
CD14, CD163 and TLR4 expression, significant TNFα production after LPS 
stimulation and phagocytic activity. Work in other species, such as humans and 
mice has demonstrated a similar phenomenon, highlighting specific 
characteristic properties of AMs, considered to reflect their unique 
microenvironment, which support the theory that AMs show a unique 
phenotype, not observed in other types of macrophages (Gonzalez-Juarrero and 
Orme, 2001; Guth et al., 2009). 
One interesting result was the failure of harvested equine PMs to produce TNFα 
in response to stimulation with LPS, Poly IC and heat killed bacteria of S. 
typhimurium. In contrast to our results, Barton et al. did describe TNFα 
production by equine PMs following LPS stimulation; however, the data 
presented demonstrated marked variation in the responses and the TNFα 
detection method differed from our study, relying on the measurement of TNFα 
activity using a cell line bioassay (Barton et al., 1996). Furthermore, other 
studies on LPS responsiveness in equine PMs have shown the response to be 
neither dose nor time dependent (Morris et al., 1990). In order to further 
investigate this apparent discrepancy in study outcomes, we performed qPCR to 
measure TNFα mRNA expression in both AMs and PMs, the results of which 
supported the ELISA data, confirming a lack of TNFα production by equine PMs. 
In agreement with our findings, several studies in mice PMs have also shown 
relatively low levels of TNFα release following LPS stimulation (Bradbury and 
Moreno, 1993; Zheng and Specter, 1996; Sherry et al., 2007; Skuladottir et al., 
2007). Indeed, it has been shown that resident murine PMs fail to actively 
respond to stimuli, necessitating activation with thyoglycolate to induce an 
inflammatory response (Hetland and Bungum, 1988; Morris et al., 1990; Zheng 
and Specter, 1996; Nomura et al., 2000). The biological reason for this apparent 
deficiency in responsiveness of equine PMs is unclear but may reflect a degree of 
LPS tolerance. Although none of the horses sampled had evidence of 
gastrointestinal disease, which may have resulted in endotoxin translocation 
across the intestinal wall, it is possible that low level endotoxin exposure may 
occur in this species which may also explain the relatively high ratio of 
neutrophils within the peritoneal cavity of all horses. Furthermore, although PM 
isolation was not performed in a completely aseptic manner, the likelihood of PM 
stimulation during the sampling period is low and had this been the case, any 
LPS tolerance should have been transient and disappeared with overnight cell 
adherence. However, if a phenomenon of ante mortem LPS tolerance exists in 
equine PMs, this is evidently not associated with TLR4 down regulation, as 
reported in murine PMs (Nomura et al., 2000). In contrast to TLR4 expression, 
the surface expression of CD14 was low in equine PMs, which likely contributed 
to their lack of LPS responsiveness. IL10, as an anti-inflammatory cytokine, is 
well documented to inhibit cytokine production, such as IL1, TNFα and IL6 by 
LPS treated macrophage cell lines and murine peritoneal macrophages 
(Fiorentino et al., 1991). Similarly, the presence of human IL10 significantly 
reduced inflammatory mediators, such as IL6, TNF and prostaglandin E2 by 
equine PMs with a particular effect on TNFα (Hawkins et al., 1998). Therefore, 
we investigated whether a similar phenomenon was present in equine PMs of 
the current study, potentially contributing towards their relative LPS non-
responsiveness, by measuring IL10 on the cell culture supernatant. However, the 
IL-10 levels remained almost undetectable in both AMs and PMs at all-time 
points (data not shown). 
Irrespective of the underlying mechanism, it is likely that this state of low LPS 
responsiveness may be normal for equine PMs despite having a common 
progenitor cell to AMs (Gorgani et al., 2008; Kapetanovic et al., 2011), consistent 
with significantly different functional and phenotypic properties. Similar to flow 
cytometry, morphological differences between AMs and PMs were also observed 
by light microscopy, supporting differentiation in their function and phenotype. 
AMs were larger in size, had a greater number of granules within their cytoplasm 
and developed a greater number of pseudopodia compared to PMs (data not 
shown). 
The greater phagocytic activity and LPS responsiveness of AMs and their surface 
expression of CD14, CD163 as well as TLR4 likely reflect the microenvironment 
within which these cells reside and the appropriateness of these inherent 
biological properties within such an environment. Our detection of TLR4 
expression on AMs was in agreement with the results of Suri et al. who reported 
TLR4 expression in healthy horse lungs (Suri et al., 2006). In the lungs there is a 
continuous challenge of AMs with airborne agents, which is not the case in the 
peritoneal cavity. Some similarities between these cell populations were 
detected, including the cell surface expression of TLR4 and CD163, a scavenger R 
specific to mononuclear cells. It is likely that the ongoing development and 
increased availability of novel monoclonal antibodies, such as CD16, should 
continue to facilitate further comparative studies of different macrophage 
populations (Noronha et al., 2012). Despite the biological reasons for the 
difference in the status of AMs and PMs, this data has demonstrated the 
importance of targeting the tissue of interest when conducting studies on 
macrophage biology, and not extrapolating from results obtained from cells 
harvested from disparate anatomical sites. 
As we relied on qPCR to support our data, it was considered important to select 
the most appropriate reference genes for result validation. We discovered the 
18S and B2M genes to represent the optimal combination of potential reference 
genes for studies on LPS-treated AMs, with 18S being the most appropriate 
single reference gene selection. To date, there have been several attempts to 
identify reference genes for a variety of equine tissues (Bogaert et al., 2006; 
Beekman et al., 2011). Our results are concordant with Zhang et al. who found 
18S and ACTB to show no significant differences in expression between the 
following horse tissues: colon, small intestine, heart, spleen, kidney, liver, lung 
and lymph nodes (Zhang et al., 2009). However in contrast to the findings of 
Zhang et al., we found B2M to be the second more stable one of our pool of genes 
(Zhang et al., 2009). Interestingly, in a study of equine airway cells derived from 
cases of Inflammatory Airway Disease, Beekman et al. recommended using a 
combination of GADPH, HPRT, SDHA and RPL32, stating GAPDH to be most 
stable (Beekman et al., 2011). Consequently, optimal housekeeping genes may 
vary remarkably, depending on cell type, tissues type, species and even disease 
status, thus highlighting the need for caution when making the appropriate 
selection to acquire reliable results. 
Previous studies have identified phenotypic similarities between human and 
equine mononuclear cells, including the identification of CD14+CD16+ 
monocytes in both species, a phenotype not reported in mice (Fingerle et al., 
1993; Sunderkotter et al., 2004; Noronha et al., 2012). Similarly, our study has 
identified functional similarities between the equine and human macrophage, 
including the up-regulation of IDO and the failure to produce nitrite in response 
to LPS stimulation. In contrast to an earlier report (Hammond et al., 1999) we 
found no evidence of LPS-induced nitrite production by both AMs and PMs, a 
finding which mirrors the response of both porcine and human macrophages 
(Weinberg et al., 1995; Hawkins et al., 1998; Kapetanovic et al., 2012). We 
suggest that the difference reflects a major divergence of promoter sequences 
between the large animals and rodents. Horses, like humans and pigs, have 
evolved differently to nocturnal animals, such as the mouse, by regulating other 
anti-bacterial genes like IDO and the vitamin D3 pathway (Thoma-Uszynski et al., 
2001; Helenius et al., 2005; Kapetanovic et al., 2012; Korf et al., 2012). In 
response to LPS, rodent macrophages induce arginine uptake and nitric oxide 
synthase (NOS) and release nitric oxide (Thoma-Uszynski et al., 2001). This 
pathway has been widely implicated in pathogen resistance. A previous study 
revealed that pig and human macrophages also fail to produce nitric oxide in 
response to LPS, and attributed this difference to a major divergence in the iNOS 
(NOS2A) promoter sequences between the species (Kapetanovic et al., 2012). We 
therefore aligned sequences of the iNOS promoter in the three species: human, 
mouse and horse and found that human and horse promoters are well 
conserved, whereas there is little alignment of the promoter sequences between 
mouse/horse and mouse/human (data not shown). 
IDO is an enzyme that catalyses tryptophan and its activation leads to a depletion 
of the amino acid which is essential for bacterial growth. The LPS-induced IDO 
gene up-regulation we detected mirrors the situation in humans and pigs and 
supports the findings of previous studies which report IDO up-regulation in 
horse AMs during intracellular bacterial infection (Heller et al., 2010). 
Interestingly, IDO gene up-regulation does not occur in murine macrophages 
despite the mouse being a commonly used model for human inflammatory 
research. Such fundamental differences in cellular biology have supported the 
use of other large animals, such as pigs, as models for human inflammatory 
diseases (Fairbairn et al., 2011; Kapetanovic et al., 2012). Our data 
demonstrating the similarities between equine and human macrophage biology 
are potentially supportive of the horse also being regarded as an appropriate 
model for human inflammatory research involving this cell type. Furthermore, 
we have demonstrated the horse to be an abundant source of macrophages, 
which could facilitate such comparative studies by permitting sequential 
examination of cells harvested from the same individual. 
 
5.Conclusion 
In summary, we have identified significant phenotypic and functional differences 
between equine AMs and PMs, a finding which likely reflects their 
microenvironment and respective roles in defence against pathogens and tissue 
homeostasis. We have explored some of the mechanisms underlying the 
functional difference in these cell populations with regard to LPS responsiveness, 
which are likely in part due to differences in CD14 expression. This information 
is crucial to the understanding of the role of macrophages in specific disease 
states and to the development of therapeutic and/or prophylactic approaches to 
such, whereby the macrophage is a candidate target cell. Finally, we have 
demonstrated significant similarities between the equine and human 
macrophage, supporting the horse as a potentially suitable model for the study of 
human macrophage biology. 
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